Financhill
Back

Invesco FTSE RAFI Developed Mkts ex-US SM ETF Vs. NovoCure Industry Stock Comparison

Buy
57

PDN
Invesco FTSE RAFI Developed Mkts ex-US SM ETF

Last Price:
$31.97
Seasonality Move:
0.65%
Sell
49

NVCR
NovoCure

Last Price:
$30.18
Seasonality Move:
-3.69%
Buy
57
Invesco FTSE RAFI Developed Mkts ex-US SM ETF (PDN) is a Buy

Is Invesco FTSE RAFI Developed Mkts ex-US SM ETF a Buy, Sell or Hold?

  • The current Invesco FTSE RAFI Developed Mkts ex-US SM ETF [PDN] share price is $31.98. The Score for PDN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • PDN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.19. The Score for NVCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PDN Stock Price Chart

What is Invesco FTSE RAFI Developed Mkts ex-US SM ETF's stock price today?

  • The Invesco FTSE RAFI Developed Mkts ex-US SM ETF share price today is $31.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PDN is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.19
    The current trend is moderately bullish and NVCR is experiencing slight selling pressure.

PDN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 43.63 Sell
Chaikin Money Flow: 19029 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.84 - 33.04) Sell
Bollinger Bands (100): (32.44 - 34.44) Sell

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.94 Buy
Relative Strength Index (14 RSI): 58.79 Buy
Chaikin Money Flow: -60501 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.36 - 32.64) Buy
Bollinger Bands (100): (14.38 - 25.86) Buy

PDN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.77 Buy
20-day SMA: 32.34 Sell
50-day SMA: 32.6 Sell
200-day SMA: 33.13 Sell
8-day EMA: 31.86 Buy
20-day EMA: 32.16 Sell
50-day EMA: 32.64 Sell
200-day EMA: 32.85 Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.52 Sell
20-day SMA: 30.41 Sell
50-day SMA: 23.25 Buy
200-day SMA: 18.89 Buy
8-day EMA: 30.36 Sell
20-day EMA: 29.22 Buy
50-day EMA: 25.18 Buy
200-day EMA: 21.21 Buy

Invesco FTSE RAFI Developed Mkts ex-US SM ETF Earnings Growth & PDN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.

Invesco FTSE RAFI Developed Mkts ex-US SM ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):